Journal Article10.1378/CHEST.113.6.1542
Infective Exacerbations of Chronic Bronchitis : Relation between Bacteriologic Etiology and Lung Function
388
TL;DR: In acute infective exacerbations, Enterobacteriaceae and Pseudomonas spp are the predominant bacteria in patients with an FEV1 < or =35% of the predicted value.
read more
About: This article is published in Chest. The article was published on 01 Jun 1998. The article focuses on the topics: Sputum culture & Sputum.
read more
Chat with Paper
AI Agents for this Paper
Find similar papers on Google Scholar, PubMed and Arxiv
Write a critical review of this paper
Analyze citations of this paper to find unaddressed research gaps
Citations
Antimicrobial treatment of lower respiratory tract infections in the hospital setting.
TL;DR: Evidence from clinical trials suggests that levofloxacin monotherapy is as efficacious as combination ceftriaxone-erythromycin therapy in the treatment of patients hospitalized with CAP, and high-dose, short-course therapy regimens may offer improved treatment due to higher drug concentrations, more rapid killing, increased adherence, and the potential to reduce development of resistance.
•Book
Chronic obstructive pulmonary disease
Peter J. Barnes
- 01 Jan 1980
TL;DR: The most important bacterial causes of exacerbations of COPD are nontypeable Haemophilus influenzae, Moraxella catarrhalis, Streptococcus pneumoniae and Chlamydia pneumoniae.
Risk factors and outcome of community‐acquired pneumonia due to Gram‐negative bacilli
Miquel Falguera,Jordi Carratalà,Agustín Ruiz-González,Carolina Garcia-Vidal,I. Gázquez,Jordi Dorca,Francesc Gudiol,José M. Porcel +7 more
TL;DR: This work sought to identify risk factors for community‐acquired pneumonia due to Gram‐negative bacilli, including Pseudomonas aeruginosa, and to assess outcomes.
Factors associated with relapse after ambulatory treatment of acute exacerbations of chronic bronchitis
TL;DR: In this article, a multivariate model was developed to identify risk factors independently associated with failures from the information recorded at the inclusion visit and at 30-day follow-up visit.
Infectious Etiology of Acute Exacerbations of Chronic Bronchitis
TL;DR: Emerging evidence from molecular epidemiology and measurement of airway inflammation further support the role of bacteria in AECB, which is likely to be infectious in origin when properly defined.
References
Standards for the Diagnosis and Care of Patients with Chronic Obstructive Pulmonary Disease
Bartolome R. Celli,Gordon L. Snider,John E. Heffner,Brian Tiep,Irwin Ziment,Barry J. Make,Sidney Braman,Gerald Olsen,Yancy Y. Phillips +8 more
- 01 Jan 1995
TL;DR: Values below this suggest that further studies, such as split func-tion assessment by quantitative lung scintigraphy and exercisetesting, are warranted, and that all elective surgery Prophylaxis against deep venous throm-bosis should be given before most procedures that will require postoperative bed rest or significantly reduce mobility.
Antibiotic Therapy in Exacerbations of Chronic Obstructive Pulmonary Disease
Nicholas R. Anthonisen,Jure Manfreda,C. P. W. Warren,Earl Hershfield,G. K. M. Harding,N. A. Nelson +5 more
TL;DR: There was a significant benefit associated with antibiotic and Peak flow recovered more rapidly with antibiotic treatment than with placebo, and side effects were uncommon and did not differ between antibiotic and placebo.
2.5K
The natural history of chronic airflow obstruction.
C. M. Fletcher,Richard Peto +1 more
TL;DR: Severe or fatal obstructive lung disease could be prevented by screening smokers' lung function in early middle age if those with reduced function could be induced to stop smoking.
2.4K
Bacterial infection in chronic obstructive pulmonary disease : a study of stable and exacerbated outpatients using the protected specimen brush
TL;DR: The lower airways of asymptomatic chronic obstructive pulmonary disease (COPD) patients can be colonized by bacteria, mainly Haemophilus influenza, Streptococcus pneumoniae, and Moraxella catarrhalis, but the role of lower airway bacteria in stable and exacerbated COPD has not been well defined.
606